Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-negative bacteria in hospitals. Methods: Cross-sectional, internet-based questionnaire survey. We contacted representatives of all hospitals with more than 800 acute-care hospital beds in France, Greece, Israel, Italy, Kosovo, Slovenia, Spain and selected hospitals in the USA. We asked respondents to describe the most common actual practice at their hospital regarding management of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa through close-ended questions. Results: Between January and June 2017, 115 of 141 eligible hospitals participated (overall response rate 81.6%, country-specific rate...
To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-nega...
To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-nega...
OBJECTIVES: Optimal treatment of carbapenem-resistant Gram-negative (CR-GNB) infections is uncertain...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
International audienceObjectives: To explore contemporary antibiotic management of infections caused...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
International audienceObjectives: To explore contemporary antibiotic management of infections caused...
To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-nega...
OBJECTIVES: To explore contemporary antibiotic management of infections caused by carbapenem-resis...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-nega...
To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-nega...
OBJECTIVES: Optimal treatment of carbapenem-resistant Gram-negative (CR-GNB) infections is uncertain...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
International audienceObjectives: To explore contemporary antibiotic management of infections caused...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
International audienceObjectives: To explore contemporary antibiotic management of infections caused...
To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-nega...
OBJECTIVES: To explore contemporary antibiotic management of infections caused by carbapenem-resis...
Objectives: To explore contemporary antibiotic management of infections caused by carbapenem-resista...
To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-nega...
To explore contemporary antibiotic management of infections caused by carbapenem-resistant Gram-nega...
OBJECTIVES: Optimal treatment of carbapenem-resistant Gram-negative (CR-GNB) infections is uncertain...